Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses - PubMed (original) (raw)

Comparative Study

Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses

P W Askenase et al. J Exp Med. 1975.

Abstract

Mice immunized with more SRBC than are required to produce optimal delayed-type hypersensitivity reactions, developed good antibody responses and poor delayed foot pad reactions. Cyclophosphamide treatment in low doses (20 mg/kg) before immunization, augmented the delayed-type hypersensitivity without affecting antibody responses. Cyclophosphamide did not augment delayed responses to optimal doses of SRBC (0.01%), but did augment the delayed hypersensitivity response of mice immunized with a suboptimal antigen dose (0.001%); which produced no detectable antibody response with or without cyclophosphamide pretreatment. These results suggest that antibody feedback is not the sole regulator of delayed reactions; the possibility that suppressor T cells may also be involved is discussed.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Immunology. 1959 Jan;2(1):53-63 - PubMed
    1. Immunol Commun. 1972;1(3):289-99 - PubMed
    1. Nature. 1974 Jun 14;249(458):654-6 - PubMed
    1. J Exp Med. 1974 Mar 1;139(3):543-59 - PubMed
    1. J Exp Med. 1974 Mar 1;139(3):528-42 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources